126 related articles for article (PubMed ID: 30536490)
1. Combined flecainide and sotalol therapy for multifocal atrial tachycardia in cardio-facio-cutaneous syndrome.
Sakurai K; Takahashi K; Nakayashiro M
Pediatr Int; 2018 Nov; 60(11):1036-1037. PubMed ID: 30536490
[No Abstract] [Full Text] [Related]
2. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
[TBL] [Abstract][Full Text] [Related]
3. Chondroblastoma-like tumor of the skull in a patient with cardio-facio-cutaneous syndrome.
Fasciano D; Wei S; Li R; Siegal GP
Pathol Res Pract; 2018 Sep; 214(9):1510-1513. PubMed ID: 30100356
[TBL] [Abstract][Full Text] [Related]
4. A girl with Cardio-facio-cutaneous syndrome complicated with status epilepticus and acute encephalopathy.
Wakusawa K; Kobayashi S; Abe Y; Tanaka S; Endo W; Inui T; Iwaki M; Watanabe S; Togashi N; Nara T; Niihori T; Aoki Y; Haginoya K
Brain Dev; 2014 Jan; 36(1):61-3. PubMed ID: 23340054
[TBL] [Abstract][Full Text] [Related]
5. A rare coincidence: the long QT syndrome and cardio-facio-cutaneous syndrome.
Giray D; Donmez YN; Epcacan S; Goktas E
Cardiol Young; 2020 Aug; 30(8):1209-1211. PubMed ID: 32635955
[TBL] [Abstract][Full Text] [Related]
6. A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation.
Sekiguchi K; Maeda T; Suenobu S; Kunisaki N; Shimizu M; Kiyota K; Handa YS; Akiyoshi K; Korematsu S; Aoki Y; Matsubara Y; Izumi T
Am J Med Genet A; 2013 Oct; 161A(10):2600-3. PubMed ID: 23950000
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review.
Adachi M; Abe Y; Aoki Y; Matsubara Y
Seizure; 2012 Jan; 21(1):55-60. PubMed ID: 21871821
[TBL] [Abstract][Full Text] [Related]
8. Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis.
Hill GD; Kovach JR; Saudek DE; Singh AK; Wehrheim K; Frommelt MA
Prenat Diagn; 2017 Nov; 37(11):1076-1083. PubMed ID: 28833310
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
Miyazaki A; Ohuchi H; Kurosaki K; Kamakura S; Yagihara T; Yamada O
Circ J; 2008 Dec; 72(12):1998-2003. PubMed ID: 18931451
[TBL] [Abstract][Full Text] [Related]
10. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
[TBL] [Abstract][Full Text] [Related]
11. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
Ermakov S; Gerstenfeld EP; Svetlichnaya Y; Scheinman MM
Heart Rhythm; 2017 Apr; 14(4):564-569. PubMed ID: 27939893
[TBL] [Abstract][Full Text] [Related]
12. Wide QRS Tachycardia in a young patient.
Hariman RJ; Khin MM; Zoble RG
Arch Intern Med; 2012 Apr; 172(7):537; discussion 538-9. PubMed ID: 22493460
[No Abstract] [Full Text] [Related]
13. Cardio-facio-cutaneous syndrome with infantile spasms and delayed myelination.
Aizaki K; Sugai K; Saito Y; Nakagawa E; Sasaki M; Aoki Y; Matsubara Y
Brain Dev; 2011 Feb; 33(2):166-9. PubMed ID: 20395089
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin Therapy for Infantile Spasms in a Case of Cardiofaciocutaneous Syndrome with Cardiac Hypertrophy Developing during Adrenocorticotropic Hormone Treatment.
Hatori T; Sugiyama Y; Yamashita S; Hirakubo Y; Nonaka K; Ichihashi K
J Nippon Med Sch; 2016; 83(4):167-71. PubMed ID: 27680485
[TBL] [Abstract][Full Text] [Related]
15. Congenital extrahepatic portosystemic shunt: An unusual feature in cardio-facio-cutaneous syndrome.
Zhen L; Han J; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():107-108. PubMed ID: 35491294
[No Abstract] [Full Text] [Related]
16. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
[TBL] [Abstract][Full Text] [Related]
17. Cardio-facio-cutaneous syndrome with precocious puberty, growth hormone deficiency and hyperprolactinemia.
Çelik N; Cinaz P; Bideci A; Yüce Ö; Emeksiz HC; Döğer E; Çamurdan O
J Clin Res Pediatr Endocrinol; 2014; 6(1):55-8. PubMed ID: 24637312
[TBL] [Abstract][Full Text] [Related]
18. Combination of flecainide and propranolol for congenital junctional ectopic tachycardia.
Imamura T; Tanaka Y; Ninomiya Y; Yoshinaga M
Pediatr Int; 2015 Aug; 57(4):716-8. PubMed ID: 25809220
[TBL] [Abstract][Full Text] [Related]
19. An acute encephalopathy with reduced diffusion in BRAF-associated cardio-facio-cutaneous syndrome.
Okuzono S; Fukai R; Noda M; Miyake N; Lee S; Kaku N; Sanefuji M; Akamine S; Kanno S; Ishizaki Y; Torisu H; Kira R; Matsumoto N; Sakai Y; Ohga S
Brain Dev; 2019 Apr; 41(4):378-381. PubMed ID: 30414707
[TBL] [Abstract][Full Text] [Related]
20. Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy.
Ermakov S; Hoffmayer KS; Gerstenfeld EP; Scheinman MM
Pacing Clin Electrophysiol; 2014 Jan; 37(1):90-4. PubMed ID: 24102153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
